Literature DB >> 20100471

Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases.

Xin Wang1, Xiao-long Ye, Rui Liu, Hong-Li Chen, Hua Bai, Xin Liang, Xiao-Di Zhang, Zhao Wang, Wen-li Li, Chun-Xu Hai.   

Abstract

Oleanolic acid (OA) is a natural triterpenoid, which has been used in Chinese medicine for the treatment of liver disorders for many years. Its pharmacological activities have been the focus of intense research in recent years. However, there is little research on the antioxidant activities of OA. In the present study, we aim to investigate whether OA produces its protective effects mainly through antioxidant mechanisms and whether OA plays as an antioxidant through quenching reactive oxygen species (ROS), inhibiting lipid peroxidation or stimulating cellular antioxidant defenses. In the in vitro antioxidant activity-assessing models, OA acted as not only a free radical-scavenger through direct chemical reactions but also a biological molecule, which may enhance the antioxidant defenses. tert-Butyl hydroperoxide (tBHP) induced ROS generation, damaged plasma membrane and decreased cell viability and the expression of key antioxidant enzymes and MAP kinases in QZG cells. OA ameliorated the oxidative injury induced by tBHP through increasing the generation of antioxidant (glutathione) and the expression of key antioxidant enzymes mediated by nuclear factorerythroid 2 p45-related factor 2 (Nrf2), in which process, activation of JNK and ERK, but not p38, was involved. The present study, for the first time, investigated the antioxidant activities of OA systematically. OA probably functions mainly through indirect biological effect and protects QZG cells against cytotoxicity induced by tBHP through increasing the generation of antioxidant and the expression of oxidative stress sensitive transcription factor-Nrf2, and MAP kinases, mainly JNK and ERK. These findings may significantly better the understanding of OA and advance therapeutic approaches to the diseases which are associated with oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100471     DOI: 10.1016/j.cbi.2010.01.034

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  47 in total

1.  Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

Authors:  Nisha R Parikh; Animesh Mandal; Deepak Bhatia; Kodappully Sivaraman Siveen; Gautam Sethi; Anupam Bishayee
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

2.  Candida albicans β-Glucan-Containing Particles Increase HO-1 Expression in Oral Keratinocytes via a Reactive Oxygen Species/p38 Mitogen-Activated Protein Kinase/Nrf2 Pathway.

Authors:  Yoko Ishida; Kouji Ohta; Takako Naruse; Hiroki Kato; Akiko Fukui; Hideo Shigeishi; Hiromi Nishi; Kei Tobiume; Masaaki Takechi
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Computational and Synthetic Investigation of Cationic Rearrangement in the Putative Biosynthesis of Justicane Triterpenoids.

Authors:  Masha Elkin; Anthony C Scruse; Aneta Turlik; Timothy R Newhouse
Journal:  Angew Chem Int Ed Engl       Date:  2018-12-21       Impact factor: 15.336

4.  The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2.

Authors:  J Wang; J Zhao; X Cui; B A Mysona; S Navneet; A Saul; M Ahuja; N Lambert; I G Gazaryan; B Thomas; K E Bollinger; S B Smith
Journal:  Free Radic Biol Med       Date:  2019-02-10       Impact factor: 7.376

5.  3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT2B, 5-HT7, or σ1 Receptor Ligands.

Authors:  Matthew R Porter; Haiyan Xiao; Jing Wang; Sylvia B Smith; Joseph J Topczewski
Journal:  ACS Med Chem Lett       Date:  2019-09-23       Impact factor: 4.345

6.  ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway.

Authors:  Jia Liu; Leina Ma; Xiao Chen; Jianxun Wang; Tao Yu; Ying Gong; Aiguo Ma; Lanhong Zheng; Hui Liang
Journal:  Tumour Biol       Date:  2015-12-29

Review 7.  Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.

Authors:  Muthu K Shanmugam; Xiaoyun Dai; Alan Prem Kumar; Benny K H Tan; Gautam Sethi; Anupam Bishayee
Journal:  Cancer Lett       Date:  2014-01-30       Impact factor: 8.679

8.  Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.

Authors:  Tonibelle N Gatbonton-Schwager; John J Letterio; Gregory P Tochtrop
Journal:  J Nat Prod       Date:  2012-02-16       Impact factor: 4.050

9.  Efficacy of MK615 for the treatment of patients with liver disorders.

Authors:  Atsushi Hokari; Tomohisa Ishikawa; Hisao Tajiri; Takahide Matsuda; Osamu Ishii; Nobuyuki Matsumoto; Chiaki Okuse; Hideaki Takahashi; Takeshi Kurihara; Ko-Ichi Kawahara; Ikuro Maruyama; Mikio Zeniya
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

Review 10.  Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: potential role in the prevention and treatment of inflammation and cancer.

Authors:  Hemavathy Harikrishnan; Ibrahim Jantan; Akilandeshwari Alagan; Md Areeful Haque
Journal:  Inflammopharmacology       Date:  2019-12-02       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.